Our results show that the downregulation of PD-L1 expression was modulated by heteronemin combined with tetrac, and its expression was also linked to blockage of the EGFR/ERK1/2 signaling cascade in HCT-116 cells (KRAS MT CRC; Figure 9B). The gene discussed is KRAS; the disease is colorectal carcinoma.